Add BrightSurf on Google Email

Precision targeting of the centromedian nucleus in drug-resistant epilepsy highlighted in brain network disorders

Researchers developed new methods to accurately target the centromedian nucleus for deep brain stimulation in patients with drug-resistant epilepsy. Advanced imaging techniques, such as high-resolution MRI and DTI tractography, improve targeting accuracy by identifying specific brain pathways and neural firing patterns.

SourceBrain Network Disorders Editorial Office·JournalBrain Network Disorders·TypeLiterature review·DateSep 16, 2025

Home training for cerebellar ataxias

Home high-intensity aerobic training outperforms home balance training in improving ataxia symptoms, fatigue, and aerobic fitness among those with cerebellar ataxias. Regular training maintained benefits at 1 year.

SourceJAMA Network·JournalJAMA Neurology·DateSep 14, 2025

Self-reported hearing aid use and risk of incident dementia

A recent study published in JAMA Neurology suggests that using hearing aids can lower the risk of developing dementia, particularly in individuals under age 70. This finding highlights the importance of early intervention for hearing loss and its potential role in preventing age-related cognitive decline.

SourceJAMA Network·JournalJAMA Neurology·DateAug 18, 2025

Brain Network Disorders Review explores biomarkers linked to rare autoimmune brain disease

Researchers identify key symptom categories and biomarkers for anti-NMDAR encephalitis, a rare autoimmune brain condition. Clinical manifestations suggest the presence of anti-NMDAR encephalitis through NMDA antibody checks, uric acid levels, C-reactive protein, and thyroid-related hormones.

SourceBrain Network Disorders Editorial Office·JournalBrain Network Disorders·TypeLiterature review·DateAug 8, 2025

Brain Network Disorders review highlights role of JAK2 pathway in worsening ischemic stroke outcomes

The JAK2-STAT3 pathway contributes to inflammation and injury after ischemic stroke. Targeting this pathway shows promise for reducing brain swelling, neuronal death, and improving recovery. Several inhibitors have been found effective in preclinical models, including Tyrphostin AG490, Ruxolitinib, and natural compounds like genistein.

SourceBrain Network Disorders Editorial Office·JournalBrain Network Disorders·TypeLiterature review·DateAug 4, 2025

Scientists advance efforts to create ‘virtual cell lab’ as testing ground for future research with live cells

Researchers develop computer program that mimics human and animal cell behavior in various parts of the body. The new 'virtual cell lab' can simulate drug responses, gene environment interactions, and other dynamic cellular molecular processes, enabling scientists to test hypotheses before conducting costly live-cell experiments.

SourceJohns Hopkins Medicine·JournalCell·DateJul 25, 2025

People with ‘young brains’ outlive ‘old-brained’ peers, Stanford Medicine scientists find

Researchers developed a blood-based indicator of organ age and found that individuals with young brains have a lower risk of developing diseases associated with their brain. The study also showed that organs' biological ages can predict health outcomes, such as increased risk of Alzheimer's disease for those with an old brain.

SourceStanford Medicine·JournalNature Medicine·TypeData/statistical analysis·DateJul 9, 2025

Mouse models for ultra-rare disorder could pave the way for nervous system gene editing therapies

Scientists developed mouse models that survive premature death, enabling pre-clinical testing of alternating hemiplegia of childhood (AHC), a devastating neurological disorder. The research reveals how different mutations can lead to distinct outcomes in AHC and sets the stage for developing gene editing therapies.

SourceJackson Laboratory·JournalNeurobiology of Disease·TypeExperimental study·DateJul 2, 2025

Chinese Neurosurgical Journal study outlines a comprehensive research design to investigate pregnancy-related stroke

A comprehensive study protocol has been developed to investigate pregnancy-related stroke risk factors and long-term implications for mothers and their children. The nationwide multicenter study aims to identify key risk factors associated with ASPP and assess its impact on offspring.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeObservational study·DateJul 2, 2025

New MRI approach maps brain metabolism, revealing disease signatures

Researchers at the University of Illinois Urbana-Champaign have developed a new non-invasive MRI approach that visualizes brain metabolism and detects metabolic alterations associated with brain diseases. The technique uses magnetic resonance spectroscopic imaging to provide insights into brain function and disease processes.

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalNature Biomedical Engineering·TypeExperimental study·DateJul 1, 2025

UCLA researchers uncover key mechanism of brain repair in vascular dementia, revealing promising therapeutic target

Researchers at UCLA Health have made a groundbreaking discovery about the mechanisms underlying vascular dementia. They found that targeting inflammation in brain blood vessels can promote brain repair and functional recovery in mice. This breakthrough highlights a potential new treatment approach for this understudied form of dementia.

SourceUniversity of California - Los Angeles Health Sciences·JournalCell·TypeExperimental study·DateJun 30, 2025

Autism linked to elevated risk of Parkinson’s disease

A large-scale study from Karolinska Institutet reports that individuals with an autism diagnosis are four times more likely to develop early-onset Parkinson's disease. The researchers believe that shared underlying biological mechanisms may be at play, particularly involving the neurotransmitter dopamine.

SourceKarolinska Institutet·JournalJAMA Neurology·TypeObservational study·DateMay 28, 2025

Research spotlight: Study provides a window into public perceptions about technological treatment options for brain conditions

A survey of over 1,000 US adults examined perceptions of four neurotechnologies: deep brain stimulation, MRI-guided focused ultrasound, transcranial magnetic stimulation, and pills. Pills were rated as the most beneficial, acceptable, and likely to be used, while DBS was seen as the second most beneficial but also the riskiest.

SourceMass General Brigham·JournalDevice·TypeData/statistical analysis·DateMay 23, 2025

Candidate drug that boosts protective brain protein in mice has potential to treat Alzheimer’s Disease

Researchers at UCLA Health identified a candidate small molecule, DDL-357, that increases concentrations of secreted clusterin, reducing toxic protein phospho-tau and improving mitochondrial function. The drug also improved memory in treated mice in maze-based cognitive tests.

SourceUniversity of California - Los Angeles Health Sciences·Journalnpj Drug Discovery·TypeRandomized controlled/clinical trial·DateMay 20, 2025